<DOC>
	<DOCNO>NCT01144091</DOCNO>
	<brief_summary>The investigator study 2 separate group : - Cardiology patient undergo invasive coronary angiography +/- PCI ( Percutaneous coronary intervention ) . - Patients undergo CT examination contrast medium . All patient receive intravenous ( I.V ) hydration 8-12h 36 48 h angiography 0.45 % saline 100ml/h . All patient receive oral N-acetyl cysteine 1200 mg twice daily , day , day angiography another 48 hour . In addition , patient assign receive oral pentoxyphylline ( P group ) placebo ( C - control group ) tablets 3 time day one day , day procedure another 48 hour . Baseline Serum Creatinine ( S.Cr ) level take angiography two day angiography . Radio-contrast nephropathy define , study , increase serum â‰¥ 25 % baseline injection radio-contrast agent . Pentoxyfylline orally active haemorheological agent treatment peripheral vascular disease , cerebrovascular disease number condition involve defective regional microcirculation . Pentoxyfylline act primarily increase red blood cell deformability , reduce blood viscosity decrease potential platelet aggregation thrombus formation ( mechanism unclear ) . Pentoxyfylline also proven significant anti inflammatory effect well anti oxidant effect , mechanism consider important patho-physiological cause contrast induce nephropathy .</brief_summary>
	<brief_title>Renal Effect Pentoxyphylline High Risk Patients Undergoing Angiography</brief_title>
	<detailed_description>Impairment renal function follow exposure intravenous radio-graphic contrast material third major cause renal hospital acquire renal dysfunction . Renal dysfunction occurs often patient chronic renal failure patient diabetes mellitus contributes morbidity mortality . Previous research work prove use volume expansion N-acetyl cysteine ( NAC ) superior volume expiation alone prevent renal impairment due radio-contrast5 . NAC potent anti oxidant may prevent CIN stop direct oxidative tissue damage improve renal hemodynamics.Pentoxyfylline also proven significant anti inflammatory effect well anti oxidant effect.Preangiographic high post-angiographic value Creatinine eGFR ( estimate glomerular filtration rate ) record . Levels biomarker Neutrophil - gelatinase - associate lipocalin ( NGAL ) test randomly 49 patient p biomarker contrast induce nephropathy . Blood serology NGAL drown patient procedure 2 hour angiography .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>Cardiology patient : 1 . Hospitalization ACS ( acute coronary syndrome ) NSTEMI Unstable Angina 2 . Diabetic patient ( treated insulin oral hypoglycemic drug ) patient basal serum creatinine great 1.3mg/dl female 1.5 mg/dl male patient . 3 . Informed consent 4 . Age 1875 Radiology patient : 1 . Radiology patient diabetic patient ( treated insulin oral hypoglycemic drug ) patient basal serum creatinine 1.3mg/dl female 1.5 mg/dl male patient . 2 . Informed consent 3 . Age 1875</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>diabetes mellitus</keyword>
	<keyword>creatinin level</keyword>
	<keyword>contrast induce nephropathy</keyword>
	<keyword>prevention contrast induce nephropathy high risk patient</keyword>
</DOC>